In Rare Cannabinoids, BioMedican Sees Alphabet Of Potential Dietary And Drug Ingredients

 
• By Malcolm Spicer

BioMedican is ready to produce CBG, cannabigerol, and THC-V, tetrahydrocannabivarin, through biosynthesis and plans by the end of the year to start making CBN, cannabinol, and THC-A, tetrahydrocannabinolic-acid.

More from Cannabis/CBD

More from Ingredients & Safety